Tag-lite Adenosine A2A receptor fluorescent probe
A2AR expressing cells labeled with Terbium
- Fully functional cell line
- Transient expression
- Ready for binding
One of four adenosine receptors found in the brain, A2A is a GPCR. A2A receptor is thought to play a role in acute and chronic neurodegenerative disorders such as cerebral ischemia or Parkinson's disease. A2A may also be involved in seizures and sleep disorders.
Cells expressing the A2A receptor are provided pre-labeled with Terbium, and can be used to conduct receptor binding studies on the aforementioned receptor.
In collaboration with Boehringer Ingelheim - Scientific Presentations
In collaboration with Bayer - Scientific Presentations
Determination of association (kon) and dissociation (koff) rates constants using the Tag-lite platform
Challenge the limits of binding kinetics studies - Application Notes
Binding Assays to measure therapeutic antitumor antibodies - Posters
Featuring a panel of experts - Videos
The gold standard technology for receptor binding studies - Videos